| scholarly article | Q13442814 |
| P50 | author | Jenny E Kanter | Q52684544 |
| Kevin D O'Brien | Q84811033 | ||
| Karin E. Bornfeldt | Q87887672 | ||
| Farah Kramer | Q125299327 | ||
| P2093 | author name string | Tomohiro Nishizawa | |
| Elaine W Raines | |||
| Xia Shen | |||
| Robert S Miyaoka | |||
| Anuradha Vivekanandan-Giri | |||
| Subramaniam Pennathur | |||
| Shelley Barnhart | |||
| Sridevi Devaraj | |||
| Valerie Z Wall | |||
| Jingjing Tang | |||
| Jason Kowitz | |||
| P2860 | cites work | The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism | Q24337667 |
| Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation | Q24682128 | ||
| Insulin resistance, hyperglycemia, and atherosclerosis | Q27011696 | ||
| Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation | Q30431948 | ||
| A novel 13C NMR method to assess intracellular glucose concentration in muscle, in vivo | Q32107102 | ||
| Succinate is an inflammatory signal that induces IL-1β through HIF-1α. | Q33652731 | ||
| Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury | Q34459819 | ||
| Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. | Q35849515 | ||
| Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. | Q36177914 | ||
| Diabetic vascular disease and the potential role of macrophage glucose metabolism | Q36199128 | ||
| HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders. | Q36603504 | ||
| Facilitated hexose transporters: new perspectives on form and function | Q36910739 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. | Q37635856 | ||
| Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis | Q37711215 | ||
| Intensive glycemic control and cardiovascular disease: an update | Q37734216 | ||
| Metabolism of inflammation limited by AMPK and pseudo-starvation | Q38074586 | ||
| Inhibition of development of abdominal aortic aneurysm by glycolysis restriction | Q39365004 | ||
| Cooperation of adenosine with macrophage Toll-4 receptor agonists leads to increased glycolytic flux through the enhanced expression of PFKFB3 gene. | Q39564669 | ||
| Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector | Q40625951 | ||
| P433 | issue | 2 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 356-365 | |
| P577 | publication date | 2014-04-13 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis | |
| P478 | volume | 7 |
| Q30996406 | Construction and analysis of correlation networks based on gas chromatography-mass spectrometry metabonomics data for lipopolysaccharide-induced inflammation and intervention with volatile oil from Angelica sinensis in rats |
| Q28072462 | Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive? |
| Q50021708 | Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk |
| Q37083092 | Does Elevated Glucose Promote Atherosclerosis? Pros and Cons |
| Q37511801 | Homocysteine Activates B Cells via Regulating PKM2-Dependent Metabolic Reprogramming |
| Q52644130 | IFN Regulatory Factor 2 Inhibits Expression of Glycolytic Genes and Lipopolysaccharide-Induced Proinflammatory Responses in Macrophages. |
| Q46381890 | Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (≥C20)-acyl chains in macrophages. |
| Q50061471 | Liver Kinase B1 Links Macrophage Metabolism Sensing and Atherosclerosis |
| Q36602809 | Macrophage Phenotype and Function in Different Stages of Atherosclerosis |
| Q38644325 | Macrophage metabolism in atherosclerosis |
| Q93166763 | Mass Spectrometry-based Label-free Quantitative Proteomics To Study the Effect of 3PO Drug at Cellular Level |
| Q26796679 | Metabolic Flexibility and Dysfunction in Cardiovascular Cells |
| Q92664771 | Metabolic influence on macrophage polarization and pathogenesis |
| Q38665200 | Metabolic regulation of adipose tissue macrophage (ATM) function in obesity and diabetes |
| Q60961590 | Metabolism Plays a Key Role during Macrophage Activation |
| Q28084835 | Metabolomics and diabetes: analytical and computational approaches |
| Q48265798 | Monocyte and macrophage immunometabolism in atherosclerosis. |
| Q89967822 | Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes |
| Q61813536 | Myeloid -Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1 |
| Q36063184 | Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes |
| Q104576046 | Origins and diversity of macrophages in health and disease |
| Q54111949 | PKM2-dependent metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis. |
| Q88732947 | Regulation of macrophage immunometabolism in atherosclerosis |
| Q89013999 | Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome |
| Q95315192 | Solute Carrier Family 37 Member 2 (SLC37A2) Negatively Regulates Murine Macrophage Inflammation by Controlling Glycolysis |
| Q89621213 | The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity |
| Q35881759 | Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture |
Search more.